MedPath

MicroPhage, Inc.

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Study of the Performance of the KeyPath MRSA/MSSA Blood Culture Test - BTA

Terminated
Conditions
Bacteremia
First Posted Date
2012-07-16
Last Posted Date
2013-01-15
Lead Sponsor
MicroPhage, Inc.
Target Recruit Count
764
Registration Number
NCT01640886
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Arizona, Infectious Disease Research, Tuscon, Arizona, United States

๐Ÿ‡บ๐Ÿ‡ธ

UCLA Clinical Laboratory, Los Angeles, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Medical University of South Carolina, Charleston, South Carolina, United States

Prospective Study Into the Performance of the MicroPhage S. Aureus/MSSA/MRSA Test Direct From Blood Culture Positives

Completed
Conditions
Bacteremia
Interventions
Device: MicroPhage S. aureus/MSSA/MRSA Blood Culture Test
First Posted Date
2010-08-18
Last Posted Date
2010-08-18
Lead Sponsor
MicroPhage, Inc.
Target Recruit Count
1165
Registration Number
NCT01184339

MicroPhage S. Aureus / MSSA / MRSA Blood Culture Beta Trial

Completed
Conditions
Bacteremia
Infection
Staphylococcal Infection
Sepsis
Interventions
Other: MicroPhage S. aureus / MSSA / MRSA Blood Culture Test (prototype)
First Posted Date
2008-12-24
Last Posted Date
2008-12-24
Lead Sponsor
MicroPhage, Inc.
Target Recruit Count
712
Registration Number
NCT00814151
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Evanston Northwestern Healthcare Research Institute, Evanston, Illinois, United States

๐Ÿ‡บ๐Ÿ‡ธ

Johns Hopkins Medical Institute, Baltimore, Maryland, United States

๐Ÿ‡บ๐Ÿ‡ธ

University of Maryland Baltimore, Baltimore, Maryland, United States

ยฉ Copyright 2025. All Rights Reserved by MedPath